Hjem › Ewing-sarkom › Ohio
Ewing-sarkom kliniske forsøg i Ohio
8 studier for Ewing-sarkom søger deltagere på steder i Ohio.
Byer i Ohio
Officiel studietekst (engelsk)
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
- Cleveland Clinic Children's, Cleveland
- Nationwide Children's Hospital, Columbus
RekruttererFase 1
Alder 1 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07194044Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Cincinnati Children's Hospital Medical Center, Cincinnati
RekruttererFase 1
Alder 12 til 85 · Alle køn · Opdateret 8. sep. 2026 · NCT03715933Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Cincinnati Children's Hospital Medical Center, Cincinnati
RekruttererFase 1/2
12 Months – 30 Years · Alle køn · Opdateret 25. aug. 2026 · NCT04851119Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
- Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 6. aug. 2026 · NCT05210374Single Arm Romiplostim to Prevent CIT
- Cincinnati Children's Hospital Medical Center, Cincinnati
RekruttererTidlig fase 1
Alder 1 og opefter · Alle køn · Opdateret 18. mar. 2026 · NCT07048249A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
- The Ohio State University Wexner Medical Center, Columbus
Rekrutterer
Alder 13 og opefter · Alle køn · Opdateret 6. feb. 2026 · NCT06387485Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
RekruttererFase 1/2
Alder 2 til 30 · Alle køn · Opdateret 3. feb. 2026 · NCT05734066A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Nationwide Children's Hospital, Columbus
RekruttererFase 2
18 Months – 40 Years · Alle køn · Opdateret 12. aug. 2025 · NCT05135975Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.